The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Google Chrome
Safari
Firefox
Edge
© 2026 Hovione
  • Linkedin
  • Facebook
  • Twitter
  • Instagram
  • Youtube
search
    en
      pt jp cn
Hovione
Home Go up
  • Products and Services
      • Contract Manufacturing Services
        • Drug Substance
        • Particle Engineering
        • Drug Product
      • Off-patent API products
        • API Portfolio
        • Exclusive partnerships
        • High value applications
      • Supporting Capabilities
        • Analytical Support
        • Capabilities
        • Continuity of Supply
        • Quality and Compliance
  • Knowledge Center
  • About Us
      • About Hovione
        • Management
        • Innovation
        • Sustainability
        • What we do
  • Contact Us
  • Press Room
  • Hovione Worldwide
  • Careers
  • Restricted Area

Search

Types

  • Article
  • Event
  • Page

Press Room

  • Press Release
  • Press Clipping
  • Article

Categories

  • Hovione New Jersey
  • Hovione Cork
  • Hovione Loures
  • Contract Manufacturing Services
  • DP - Drug product
  • PE - Particle Engineering
  • Hovione Japan
  • Hovione Mumbai
  • PE - Spray drying
  • Homepage
  • Hovione Macau
  • Off-patent API
  • Hovione Shanghai
  • DP - Inhalation formulation
  • Hovione Hong Kong
  • Hovione Switzerland
  • Integrated Offering
  • PE - Drug delivery platforms
  • About Hovione
  • Analytical support
  • Continuous Manufacturing
  • DP - DPI devices
  • DS - High potency handling
  • Hovione Lisboa
  • PE - Inhalable particles
  • PE - Spray congealing
  • R&D
  • (-) DS - Drug Substance
  • (-) Hovione Lumiar
View
Press Release / Nov 11, 2021

Hovione invests $170 million in new capacity and capabilities

Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives

View
Press Clipping / Jun 22, 2020

One molecule’s journey from discovery to market

C&EN, June 22, 2020

Hovione Capacity Expansion

Hovione is Growing

View
Article / Sep 27, 2021

How the drug services industry found itself prepared for a pandemic

C&EN, 26 September 2021

Hovione Lumiar

Office and R&D Center

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 1
  • Current page 2
Analytical Support
Quality and Compliance
Capabilities
Continuity of Supply
Track Record/cGMP Compliance
Regulatory Affairs
Continuity of Supply
  • Hovione Worldwide
  • Events
  • Press Room
  • Careers
  • Customers
  • Suppliers
Contacts
Lindenstrasse 14
6340 Baar
Switzerland
  • Linkedin
  • Facebook
  • Twitter
  • Instagram
  • Youtube
  • Privacy Notice
  • Terms and Conditions
    • Linkedin
    • Facebook
    • Twitter
    • Instagram
    • Youtube
  • Hovione Worldwide
  • Events
  • Press Room
  • Careers
  • Customers
  • Suppliers
  • Contacts
    Lindenstrasse 14
    6340 Baar
    Switzerland
    © 2026 Hovione
    © 2026 Hovione
    • Privacy Notice
    • Terms and Conditions